Evidence map›Paper›PMID 21520937›Full record

ArticleJournal of chemical information and modeling2011

Inhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.

Xuemei Wang, Shanshan Wu, Dingguo Xu, Daiqian Xie, Hua Guo

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xuemei WangKey Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University , Chengdu, Sichuan 610064, China.
Shanshan Wu
Dingguo Xu
Daiqian Xie
Hua Guo
Sichuan University · CNNanjing University · CNUniversity of New Mexico · US

Funding

Mechanism and Inhibition of Arginine DeiminaseR03AI071992 · NIAID · UNIVERSITY OF NEW MEXICO · PI GUO, HUA · 2009 to 2010
$150k
NIAID NIH HHS R03 AI071992NIAID NIH HHS R03-AI071992
6 · The paper itself

Abstract

Angiotensin-converting enzyme (ACE) is an important zinc-dependent hydrolase responsible for converting the inactive angiotensin I to the vasoconstrictor angiotensin II and for inactivating the vasodilator bradykinin. However, the substrate binding mode of ACE has not been completely understood. In this work, we propose a model for an ACE Michaelis complex based on two known X-ray structures of inhibitor-enzyme complexes. Specifically, the human testis angiotensin-converting enzyme (tACE) complexed with two clinic drugs were first investigated using a combined quantum mechanical and molecular mechanical (QM/MM) approach. The structural parameters obtained from the 550 ps molecular dynamics simulations are in excellent agreement with the X-ray structures, validating the QM/MM approach. Based on these structures, a model for the Michaelis complex was proposed and simulated using the same computational protocol. Implications to ACE catalysis are discussed.

Indexed as

Molecular Dynamics SimulationAngiotensin-Converting Enzyme InhibitorsCatalytic DomainCrystallography, X-RayEnalaprilatHumansHydrogen BondingLisinoprilMalePeptidyl-Dipeptidase AProtein BindingQuantum TheorySubstrate SpecificityTestisZincAngiotensin-Converting Enzyme InhibitorsEnalaprilatLisinoprilPeptidyl-Dipeptidase AZinc

Identifiers

PMID21520937
PMCPMC3156973
OpenAlexW2037966597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.